Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates

Calcified Tissue International

Volumn 63, Issue 5, 1998, Pages 363-368

  Rosen, H N ^a,e   Moses, A C ^a   Garber, J ^a,b   Ross, D S ^c   Lee, S L ^d   Greenspan, S L ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b Health Centers Division   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Bone resorption; Bone turnover; Bone specific alkaline phosphatase; Deoxypyridinoline; N telopeptide cross links

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN TYPE 1; CREATININE; DEOXYPYRIDINOLINE; OSTEOCALCIN; PAMIDRONIC ACID; PARATHYROID HORMONE; PLACEBO; PYRIDINIUM DERIVATIVE; THYROXINE;

ADULT; ARTICLE; BLOOD LEVEL; BONE TURNOVER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THYROID PAPILLARY CARCINOMA; URINARY EXCRETION;

ALKALINE PHOSPHATASE; AMINO ACIDS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BONE AND BONES; BONE RESORPTION; CARCINOMA, PAPILLARY; COLLAGEN; COLLAGEN TYPE I; CREATININE; DIPHOSPHONATES; DOUBLE-BLIND METHOD; FASTING; HUMANS; OSTEOCALCIN; OSTEOLYSIS; PEPTIDES; THYROID NEOPLASMS; THYROXINE;

EID: 0031690523     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900541     Document Type: Article

References (25)

1. Calvo MS, Eyre DR, Gundberg CM (1996) Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 17:333-368
2. Taylor AK, Lueken SA, Libanati C, Baylink DJ (1994) Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin N A 20:589-607
3. Cosman F, Nieves J, Wilkinson C, Schnering D, Shen V, Lindsay R (1996) Bone density change and biochemical indices of skeletal turnover. Calcif Tissue Int 58:236-243
4. Sugimoto AK, Hodsman AB, Nisker JA (1993) Long-term gonadotropin-releasing hormone agonist with standard postmenopausal estrogen replacement failed to prevent vertebral bone loss in premenopausal women. Fertil Steril 60:672-674
5. Genant HK, Cann CE, Ettinger B, Gordan GS (1982) Quantitative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med 97:699-705
6. Ettinger B, Genant HK, Cann CE (1987) Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med 106:40-45
7. Mattson RH, Cramer JA, Darney PD, Naftolin F (1986) Use of oral contraceptives by women with epilepsy. JAMA 256:238-240
8. Fleisch H (1993) Bisphosphonates-preclinical. In: Fleisch H (ed) Bisphosphonates in bone disease: from the laboratory to the patient. University of Berne, Berne, p 33
9. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD (1995) Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 10:641-649
10. Blumsohn A, Naylor KE, Assiri AMA, Eastell R (1995) Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget's disease. Clin Chem 41: 1592-1598
11. Rosen HN, Dresner-Pollak R, Moses AC, Rosenblatt M, Zeind AJ, Clemens JD, Greenspan SL (1994) Specificity of urinary excretion of cross-linked N-telopeptides of type 1 collagen as a marker of bone turnover. Calcif Tissue Int 54:26-29
12. Ju H, Leung S, Brown B, Stringer MA, Leigh S, Scherrer C, Shepard K, Jenkins D, Knudsen J, Cannon R (1997) Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem 43:1570-1576
13. Hanson DA, Weis ME, Bollen A-M, Maslan SL, Singer FR, Eyre DR (1992) A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 7:1251-1258
14. Bollen AM, Martin MD, Leroux BG, Eyre DR (1995) Circadian variation in urinary excretion of bone collagen cross-links. J Bone Miner Res 10:1885-1890
15. Schlemmer A, Hassager C, Jensen SB, Christiansen C (1992) Marked diurnal variation in urinary excretion of pyridium cross-links in premenopausal women. J Clin Endocrinol Metab 74:476-480
16. Rosen HN, Moses AC, Garber J, Ross DS, Lee S, Ferguson L, Chen V, Lee K, Greenspan SL (1998) Randomized trial of pamidronate in patients with thyroid cancer: bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate J Clin Endocrinol Metab 83:2324-2330
17. Gomez B, Ardakani S, Evans BJ, Merrell LD, Jenkins DK, Kung VT (1996) Monoclonal antibody assay for free urinary pyridinium crosslinks. Clin Chem 42:1168-1175
18. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ (1994) Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 9:1643-1649
19. Gomez BJ, Ardakani S, Ju J, Jenkins D, Cerelli MJ, Daniloff GY, Kung VT (1995) Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 41:1560-1566
20. Rosen CJ, Chestnut CH, Mallinak NJS (1997) The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab 82:1904-1910
21. Greenspan SL, Dresner-Pollak R, Parker RA, London D, Ferguson L (1997) Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int 60:419-423
22. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD (1994) Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693-1700
23. Pedrazzoni M, Alfano FS, Gatti C, Fantuzzi M, Girasole G, Campanini C, Basini G, Passeri M (1995) Acute effects of bisphosphonates on new and traditional markers of bone resorption. Calcif Tissue Int 57:25-29
24. Garnero P, Sornay-Rendu E, Chapuy M, Delmas PD (1996) Increased bone turnover in late post-menopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337-349
25. Schneider DL, Barret-Connor EL (1997) Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density. Arch Intern Med 157:1241-1245